| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |